IDAHO FALLS – Idaho State University’s Idaho Accelerator Center has achieved a milestone in nuclear medicine that promises hope to cancer patients. Scientists at the Center have used linear accelerators to produce isotopes that now can be assessed in the treatment of cancer.
Furthermore, ISU has received a production license from the Nuclear Regulatory Commission to use nuclear accelerators to produce the isotope copper-67, which has the potential to be more effective than chemotherapy or external radiation for the treatment of some cancers.
“We will be the only university in the western United States with production license to produce this type of cancer-fighting isotope using e-LINAC accelerators,” said Howard Grimes, vice president for research. “The potential medical and commercial implications of producing these isotopes are huge as is the potential to add to our array of cancer fighting treatments.”